Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
AIM

Updated 10/6/2026, 2:28 PM ET.

AIM

AIM ImmunoTech Inc.

Buy$4,992

Equels Thomas K

CEO & President, Director

24,000 shat $0.21Filed Sep 18, 8:30 AM ETFiling
AIM

AIM ImmunoTech Inc.

Buy$2,310

Equels Thomas K

CEO & President, Director

11,000 shat $0.21Filed Sep 17, 12:01 PM ETFiling
AIM

AIM ImmunoTech Inc.

Buy$4,862

Equels Thomas K

CEO & President, Director

22,000 shat $0.22Filed Sep 16, 9:15 AM ETFiling
AIM

AIM ImmunoTech Inc.

Buy$1,292

Equels Thomas K

CEO & President, Director

5,900 shat $0.22Filed Sep 15, 4:30 PM ETFiling

Read from public SEC filings. Not financial advice.